The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy

類似資料

• Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
  著者:: Liu, Hongchuan, 等
  出版事項: (2019)
• Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
  著者:: Liu, Kefang, 等
  出版事項: (2017)
• Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy
  著者:: Liu, Hongchuan, 等
  出版事項: (2020)
• Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
  著者:: Tan, Shuguang, 等
  出版事項: (2016)
• Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
  著者:: Tan, Shuguang, 等
  出版事項: (2017)